carbapenems has been researched along with Neoplasms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, SL; Gerges, BZ; Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA | 1 |
| Gutiérrez-Durán, OA; Hoyos-Pulgarín, JA | 1 |
| Aponte-Barrios, N; Arcila, EM; Bravo, AM; Bustos-Paz, M; Calle, JP; Camacho-Moreno, G; Cantor, E; Cárdenas, VC; Correa, AM; Dávalos, DM; Díaz, A; Escobar, JJ; Hurtado, IC; López, P; López-Cubillos, JF; López-Medina, E; Portilla, CA; Ramirez, O; Tierradentro, TM; Torres, D | 1 |
| Abd-Al-Ridha Al-Abdullah, A; Ali Albadery, A; Shakir Mahdi Al-Amara, S | 1 |
| Dou, Q; Hu, Y; Huang, Z; Li, J; Liu, J; Tao, X; Wang, H; Zou, M | 1 |
| Bodro, M; Boix, L; Calvo, M; Carratalà, J; Contra, A; Domingo-Domenech, E; Garcia-Vidal, C; Gudiol, C; Tubau, F | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Adachi, J; Bonomo, RA; Perez, F | 1 |
| Hawari, FI; Le, J; Nazer, LH; Rihani, S | 1 |
| Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Ishiyama, K; Nakao, S; Senda, Y; Yamauchi, H; Yamazaki, H | 1 |
| Watanabe, K | 1 |
| Bhusal, Y; Mihu, CN; Rolston, KV; Tarrand, JJ | 1 |
| B Hamadeh, M; Bonnin, RA; Ghazawi, A; Hashmey, R; Nordmann, P; Pál, T; Poirel, L; Rizvi, TA; Sonnevend, A | 1 |
| Cai, YY; Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Lim, CL; Lingegowda, PB; Ong, RW; Tang, SS; Teo, J | 1 |
| Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY | 1 |
| Dvorak, T; Gonzalez, V; Graviss, L; Hachem, R; Hackett, B; Hanna, H; Hogan, H; Ohmagari, N; Perego, C; Raad, I; Rolston, K | 1 |
| Aisenberg, G; Dickey, BF; Kontoyiannis, DP; Raad, II; Rolston, KV; Safdar, A | 1 |
| Chemaly, RF; Ghanem, G; Hachem, R; Jiang, Y; Raad, I | 1 |
| Amsallem, D; Balbo, L; Castagnola, E; Cometta, A; Engelhard, D; Estavoyer, JM; Ferster, A; Giacchino, M; Giacchino, R; Gibson, B; Glauser, MP; Massimo, L; Shapiro, M; Viscoli, C | 1 |
3 review(s) available for carbapenems and Neoplasms
| Article | Year |
|---|---|
Antibiotic-resistant gram-negative bacterial infections in patients with cancer.
Topics: Acinetobacter baumannii; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia | 2014 |
[Fever in patients with cancer].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbapenems; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Naproxen; Neoplasms; Neutropenia; Opportunistic Infections; Vancomycin | 2009 |
Empirical treatment of fever in neutropenic children: the role of the carbapenems. International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer and the Gimema Infection Program.
Topics: Carbapenems; Child; Fever; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia | 1996 |
1 trial(s) available for carbapenems and Neoplasms
| Article | Year |
|---|---|
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
17 other study(ies) available for carbapenems and Neoplasms
| Article | Year |
|---|---|
In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer.
Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa | 2022 |
[Risk of infection in cancer patients colonized by extended expectrum p-lactamases and carbapenem producing Enterobacteriaceae].
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hypoalbuminemia; Klebsiella pneumoniae; Neoplasms; Neutropenia; Retrospective Studies | 2022 |
Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study.
Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Female; Gammaproteobacteria; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasms; Retrospective Studies; Sepsis | 2023 |
Phenotyping and Genotyping Evaluation of
Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Genotype; Humans; Iraq; Neoplasms; Urinary Tract Infections | 2023 |
Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Carbapenems; Child; Child, Preschool; China; Female; Hematologic Diseases; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Neoplasms | 2014 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
Leuconostoc bacteremia in three patients with malignancies.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Female; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Male; Middle Aged; Neoplasms | 2011 |
Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Cancer Care Facilities; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Retrospective Studies; United States; Urine | 2011 |
NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Female; Genotype; Humans; Middle Aged; Molecular Sequence Data; Molecular Typing; Neoplasms; Sequence Analysis, DNA; United Arab Emirates; Urine | 2012 |
Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; Calcitonin; Calcitonin Gene-Related Peptide; Carbapenems; Drug Monitoring; Female; Humans; Male; Middle Aged; Neoplasms; Protein Precursors; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2012 |
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan | 2005 |
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors | 2005 |
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
Topics: Adult; Aged; Bacteremia; Carbapenems; Case-Control Studies; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Neoplasms; Neutropenia; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Texas | 2007 |
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Topics: Adult; Aged; Aminoglycosides; Bacteremia; Carbapenems; Case-Control Studies; Cross Infection; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Texas; Vancomycin Resistance | 2007 |